Related Experiment Videos
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Real-time reverse-transcription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion.
The International journal of biological markers·2017
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer.
Methods in enzymology·2016
[Systemic treatment of brain metastases from breast cancer].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2015
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).
Annals of oncology : official journal of the European Society for Medical Oncology·2014
[What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?].
Gynecologie, obstetrique & fertilite·2014
Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody-drug conjugates: A literature review.
European journal of cancer (Oxford, England : 1990)·2026
Safety and tolerability of anselamimab in participants with light chain amyloidosis: Results from a phase 2 study.
European journal of cancer (Oxford, England : 1990)·2026
Direct Tumor-Adipocyte Contact as a Prognostic Biomarker in Resected Pancreatic Ductal Adenocarcinoma.
European journal of cancer (Oxford, England : 1990)·2026
Biomarker-defined benefit from FLOT plus nivolumab in metastatic gastroesophageal cancer: Extended follow-up and immune-inflammatory markers of the phase II IKF-AIO-moonlight trial.
European journal of cancer (Oxford, England : 1990)·2026
Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study.
European journal of cancer (Oxford, England : 1990)·2026
Geneo study: Comprehensive genomic profiling versus limited local reimbursed NGS panels within the belgian Precision initiative.
European journal of cancer (Oxford, England : 1990)·2026